In Vitro Activity of Ramoplanin against Clostridium difficile, Including Strains with Reduced Susceptibility to Vancomycin or with Resistance to Metronidazole

We evaluated the in vitro activity of ramoplanin, an antimicrobial compound that inhibits cell wall synthesis by acting at the level of lipid intermediate formation, against Clostridium difficile. We included strains with reduced susceptibilities to vancomycin (vancomycin-intermediate [Van(i)] strai...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Peláez, T., Alcalá, L., Alonso, R., Martín-López, A., García-Arias, V., Marín, M., Bouza, E.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2005
Assuntos:
Susceptibility
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC549223/
https://ncbi.nlm.nih.gov/pubmed/15728918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.3.1157-1159.2005
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares